ESC Premium Access

Limitations of current therapies in real world - Clinical cases


Topic: Chronic Heart Failure
Sponsored by Bayer AG

Congress Presentation

About the speaker

Professor Justin Ezekowitz

University of Alberta, Edmonton (Canada)
7 presentations
1 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)


Residual risk is still a challenge in HFrEF patients in the modern era

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)


sGC-cGMP: currently an untapped pathway in HFrEF

Speaker: Professor J. Butler (Dallas, US)


Questions and answers - Closing

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)


Access the full session

New approach for worsening chronic heart failure

Speakers: Professor J. Ezekowitz, Professor F. Zannad, Professor F. Zannad, Professor J. Butler, Professor F. Zannad

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb